seekingalpha.com · 11 jul

The REIT Strategy I Would Use To Retire Today

Retirement income requires more than just high yield. REIT funds may not be the best solution. A balanced REIT portfolio can offer income and growth.

forbes.com · 9 jul

The 12.9% Monthly Dividend That Quietly Eats Your Portfolio

In the working world, paychecks show up every two weeks. Or at least, every month.

zacks.com · 7 jul

Why Investors Need to Take Advantage of These 2 Finance Stocks Now

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

globenewswire.com · 5 jul

InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China

BEIJING, July 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the clinical trial of novel CDH17 targeted ADC, ICP-B208, in China. Developed from InnoCare's in-house ADC platform, ICP-B208 is a novel ADC comprising a humanized anti-CDH17 monoclonal antibody conjugated to a potent, in-house invented payload via a protease-cleavable linker.

247wallst.com · 5 jul

5 Safe Monthly Pay Dividend Stocks Boomers Love in July

Income investors heading into July face a friendlier setup than they did just six weeks ago.

seekingalpha.com · 4 jul

My 5 Greatest REIT Winners Of All Time

Iron Mountain, Tanger, Four Corners, Essential Properties, and Chatham Lodging delivered outsized REIT returns by exploiting price-value gaps during market panics. My disciplined value investing approach focuses on durable business models, strong balance sheets, and buying below intrinsic value, not market timing or headline chasing. IRM and SKT now trade at premium valuations, while EPRT and FCPT remain attractively priced with solid growth and conservative payout ratios; CLDT reached fair value and was exited.

prnewswire.com · 1 jul

ADC Therapeutics Announces New Employee Inducement Grant

LAUSANNE, Switzerland, July 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made a grant of options to purchase an aggregate of 17,000 of the Company's common shares to a new employee on July 1, 2026 ("Grant"). The Grant was offered as material inducement to the employee's employment.

gurufocus.com · 30 jun

Agree Realty Announces Second Quarter 2026 Earnings Release Date and Conference Call Information

Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced that it will release its second quarter 2026 operating results after the market closes